Germany’s BioNTech Settles With US Agency, UPenn Over COVID Vaccine Royalties

Share!

Insurance Journal - Dec 27, 2024

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings. The German company, which partners …...

Read Full Article

Recommended Articles

Washington Excavator Fined $140K for Workplace Safety Violations

Posted: Sep 19, 2025

A Clark County, Washington excavating company was fined $140,500 for knowingly putting workers in da...

UK Teenager Charged by US for Role in Yearslong Hack Spree

Posted: Sep 18, 2025

The US Justice Department accused a British teenager on Thursday of engaging in a yearslong spree of...

Banks Should NOT be Asking for Additional Insured Status

Posted: Sep 18, 2025

We welcome back to the Academy Journal Christopher Boggs, Chief Consultant with Boggs Risk & Ins...